Uniconazole TC, WP, SC

Uniconazole, %

≥90.0

Paclobutrazol, %

≤3.0

Moisture, %

≤0.5

Acetone insolubles, %

≤0.5

Acidity (as H2SO4), %

≤0.2

Uniconazole, %

5.0±0.5

Paclobutrazol, %

≤0.2

Moisture, %

≤3.0

pH

6.0 - 10.0

Wet sieve test (passed 75 μm sieve), %

≥98

Suspension, %

≥80

Persistent foamability (after 1 min), ml

≤60

Wetting time, s

≤120

Stability at elevated temperature

After storage at 54 ± 2°C for 14 days, the   determined average active ingredient content must not be lower than 95 %   relative to the determined average content found before storage and the   formulation shall continue to comply with the clauses for:Content, pH,   wet sieve test, suspension rate, and wetting time shall still comply with the   requirements of this document.

Mass fraction of Uniconazole (E-isomer), %

10.0 ± 1.0

Suspension rate, %

≥ 90

Pourability

Residual after pouring, % ≤ 5.0

Residual after rinsing, % ≤ 0.5

pH value

5.0∼9.05.0∼9.0

Wet sieve test (passed 75 μm sieve), %

≥ 98

Persistent foamability (after 1 min), ml

≤ 25

Low-temperature stability

After low-temperature storage, the   suspension rate and wet sieve test results shall still comply with the   requirements of this document.

Stability at elevated temperature

After storage at 54 ± 2°C for 14 days, the   determined average active ingredient content must not be lower than 95 %   relative to the determined average content found before storage and the   formulation shall continue to comply with the clauses for: the   suspension rate, pourability, pH, and wet sieve test results shall still   comply with the requirements of this document.